Literature DB >> 17221038

Evolutive echocardiographic study of the structural and functional heart alterations in obese individuals after bariatric surgery.

Luciana de Cerjat Bernardes P Cunha1, Cláudio L Pereira da Cunha, Admar Moraes de Souza, Nelson Chiminacio Neto, Ricardo Soares Pereira, Henrique Lacerda Suplicy.   

Abstract

OBJECTIVE: To evaluate with Doppler echocardiography the reversibility of structural and hemodynamic changes in obeses after bariatric surgery.
METHODS: Twenty-three patients (19 women = 82.6%) were studied. Mean age was 37.9 years. All subjects had Class III or Class II obesity with comorbidity and were submitted to bariatric surgery. Clinical and echocardiographic evaluation were performed preoperatively, in 6 months and 3 years after surgery.
RESULTS: Preoperatively, the mean weight and blood pressure (BP) were respectively 128.7 +/- 25.8 kg and 142.2 +/- 16.2 / 92.2 +/- 10.4 mmHg. Postoperatively, they showed important body weight reduction in 6 months (97.6 +/- 18.3 kg) and 3 years (83.6 +/- 13.5 kg), and BP reduction in 6 months (128.5 +/- 16.1/80.7 +/- 9.9 mmHg) that remain stable in 3rd year. On echocardiogram, preoperatively, there was hypertrophy of the septum and posterior wall associated with normal diastolic dimension; the predominant LV geometric pattern was concentric remodeling (74%). At six months, thinning of the ventricular septum and LV posterior wall, and increase in LV diastolic dimension were demonstrated. At 3rd year, the predominant LV pattern was normal (69%), with reduction of LV mass and LV mass/height2 index. We noticed improved diastolic function, with an increased E/A ratio and a decreased LV isovolumic relaxation time. The Myocardial Performance Index was obtained retrospectively in 13 patients and improved in 6 months. There was an increase of the ejection time in 6 months and an elevation of the ejection fraction in 3rd year, suggesting improvement of the LV systolic function.
CONCLUSION: The weight loss obtained with bariatric surgery promotes both structural and functional myocardial changes that improve cardiac performance.

Entities:  

Mesh:

Year:  2006        PMID: 17221038     DOI: 10.1590/s0066-782x2006001800011

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  6 in total

1.  Potential Errors and Omissions Related to the Analysis and Conclusions Reported in Cuspidi C, et al., AJH 2014; 27(2):146-156.

Authors:  Kathryn A Kaiser; Mariel A Parman; Eric Kim; Brandon J George; David B Allison
Journal:  Am J Hypertens       Date:  2016-06       Impact factor: 2.689

2.  Short-Term Changes in Cardiovascular Hemodynamics in Response to Bariatric Surgery and Weight Loss Using the Nexfin® Non-invasive Continuous Monitoring Device: a Pilot Study.

Authors:  Sjaak Pouwels; Bianca Lascaris; Simon W Nienhuijs; Arthur R Bouwman; Marc P Buise
Journal:  Obes Surg       Date:  2017-07       Impact factor: 4.129

3.  Morphofunctional evaluation of the heart of obese patients before and after bariatric surgery.

Authors:  Antonio Carlos Valezi; Vitor Hugo Soares Machado
Journal:  Obes Surg       Date:  2011-11       Impact factor: 4.129

Review 4.  The Effects of Bariatric Surgery on Cardiac Structure and Function: a Systematic Review of Cardiac Imaging Outcomes.

Authors:  Ravi Aggarwal; Leanne Harling; Evangelos Efthimiou; Ara Darzi; Thanos Athanasiou; Hutan Ashrafian
Journal:  Obes Surg       Date:  2016-05       Impact factor: 4.129

Review 5.  Bariatric surgery as a treatment for heart failure: review of the literature and potential mechanisms.

Authors:  Tammy L Kindel; Jennifer L Strande
Journal:  Surg Obes Relat Dis       Date:  2017-10-02       Impact factor: 4.734

6.  Improvement of Cardiac Function After Roux-en-Y Gastric Bypass in Morbidly Obese Patients Without Cardiac History Measured by Cardiac MRI.

Authors:  Dennis de Witte; Leontine H Wijngaarden; Vera A A van Houten; Marinus A van den Dorpel; Tobias A Bruning; Erwin van der Harst; René A Klaassen; Roelf A Niezen
Journal:  Obes Surg       Date:  2020-07       Impact factor: 4.129

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.